Dr. Daniel C. Voglewede , MD
Urology • El Paso, TX
7420 Remcon Cir, Bldg A
El Paso, TX 799123508
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on February 3, 2006; this date does not establish years in practice.
-
Published CMS data list 8,708 Original Medicare Part B services in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Published rows only; this is not a quality measure.
-
Published Part B service records, 2023:
- J0897 — Injection, denosumab, 1 mg: 8,160 service units.
- J9217 — Leuprolide acetate (for depot suspension), 7.5 mg: 216 service units.
- 99215 — Established patient outpatient office visit: 172 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2022 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2023). CPT notice
See all 6 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 634 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Erleada (Apalutamide) — 225 prescription fills, including refills.
- Xtandi (Enzalutamide) — 126 prescription fills, including refills.
- Orgovyx (Relugolix) — 90 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 8 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 75% of clinicians listed under Urology in El Paso, TX (2024, 14 clinicians with data). Median for this group: 1,467. Middle half: 657 to 4,517.
Fewer Part D prescriptions than 65% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: 1,254. Middle half: 393 to 2,342.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 5,592 in 2019 to 8,708 in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019–2023.
Practice Location & Contact Primary Location
7420 Remcon Cir
Bldg A
El Paso, TX 799123508
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $257,774 in 2023
The total amount Medicare approved for these services in 2023. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
Paid by Medicare
About $205,002 in 2023
The part of the Medicare-allowed amount that Medicare itself paid in 2023, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
30-day fills
640 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$6,406,895 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $13.81 in 2024
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2024.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Voglewede has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Voglewede as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in El Paso and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 75% of clinicians listed under Urology in El Paso, TX (2024, 14 clinicians with data). Median for this group: 1,467. Middle half: 657 to 4,517.
Fewer Part D prescriptions than 65% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: 1,254. Middle half: 393 to 2,342.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in El Paso, TX (2024, 14 clinicians with data). Median for this group: $288,014. Middle half: $78,654 to $410,189.
A higher Part D drug cost than 95% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: $146,128. Middle half: $29,835 to $354,962.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Voglewede are from 2023.
22 active clinicians are listed under Urology with a practice address in El Paso, TX (961 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in El Paso
13.6% of these 22 clinicians have the CMS telehealth indicator.
63.6% of these 22 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 56% from 5,592 in 2019 to 8,708 in 2023.
- 2019: 5,592
- 2020: 6,687
- 2021: 15,160
- 2022: 9,218
- 2023: 8,708
-
Medicare-allowed amount
Medicare-allowed amount stayed about the same: $258,956 in 2019 and $257,774 in 2023.
- 2019: $258,956
- 2020: $271,428
- 2021: $336,441
- 2022: $262,465
- 2023: $257,774
-
Paid by Medicare
Paid by Medicare varied from year to year: $193,683 in 2019 and $205,002 in 2023.
- 2019: $193,683
- 2020: $203,870
- 2021: $267,411
- 2022: $209,229
- 2023: $205,002
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 83% from 3,787 in 2020 to 634 in 2024.
- 2020: 3,787
- 2021: 1,591
- 2022: 1,159
- 2023: 1,386
- 2024: 634
-
30-day fills
30-day fills decreased 92% from 7,588 in 2020 to 640 in 2024.
- 2020: 7,588
- 2021: 2,721
- 2022: 1,361
- 2023: 1,619
- 2024: 640
-
Part D drug cost
Part D drug cost varied from year to year: $5,853,508 in 2020 and $6,406,895 in 2024.
- 2020: $5,853,508
- 2021: $9,212,222
- 2022: $11,291,367
- 2023: $14,464,580
- 2024: $6,406,895
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 100% from $7,708.56 in 2020 to $13.81 in 2024.
- 2020: $7,708.56
- 2021: $21,805.77
- 2022: $46,065.79
- 2023: $31,893.63
- 2024: $13.81
Sources: CMS Medicare Physician & Other Practitioners (2023), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 – December 31, 2024): fewer than 11 records totaling $13.81.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
Rezum Generator | General | $13.81 |
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2022 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2023; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0897
Injection, denosumab, 1 mg
|
8,160 | 27 | $38.00 | $22.83 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
216 | 23 | $600.00 | $167.96 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
172 | 68 | $290.00 | $171.91 |
|
96372
Injection of drug or substance under skin or into muscle
|
81 | 26 | $35.00 | $13.77 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
58 | 26 | $66.00 | $32.78 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
21 | 15 | $200.00 | $124.62 |
Source: CMS Part B by Provider and Service, 2023; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Erleada | Apalutamide | 225 | 6,750 | $3,225,151.29 | 46 |
| Xtandi | Enzalutamide | 126 | 3,780 | $1,705,605.70 | 24 |
| Orgovyx | Relugolix | 90 | 2,700 | $233,113.06 | 15 |
| Nubeqa | Darolutamide | 82 | 2,460 | $1,077,160.01 | 16 |
| Prednisone | Prednisone | 43 | 1,470 | $136.71 | — |
| Abiraterone Acetate | Abiraterone Acetate | 38 | 1,140 | $16,844.70 | — |
| Methylprednisolone | Methylprednisolone | 15 | 450 | $193.67 | — |
| Yonsa | Abiraterone Acet,submicronized | 15 | 450 | $148,689.45 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20080804000223
TX
8628142023
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Acute Care
NURSEPRACTITIONER
Urology
ACNPCAG
Nurse Practitioner - Family
Family Nurse Practitioner (Board Certified)
Urology
Urology
Doctor of Medicine (M.D.)
Radiology - Therapeutic Radiology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated February 03, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in El Paso
- Lauren Eisenberg, D, O
- Dr. Erwin Tieva, MD
- Dr. Michael Bagg, MD
- Dr. Javier Arenas, MD
- Dr. Javier Lozano, MD
- Dr. Jesus Herrera-Murillo, MD
Mailing Address
7420 Remcon Cir, Bldg A
El Paso, TX 799123508
Phone: 9155328823